Belgium· BE-AMP-SAM301786-00
Pergoveris 150 IU - 75 IU
A gonadotropine, kombinationen product containing lutropin alfa, registered in Belgium by Merck Europe. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Gonadotropine, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC G03GA30 (gonadotropine, kombinationen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Gonadotropine, kombinationen · ATC G03GA30
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Lutropin Alfa
- Manufacturer
- Merck Europe
- Country
- Belgium (BE)
- ATC code
- G03GA30
- ATC class
- Gonadotropine, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb2552073
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gonadotropine, kombinationen in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandLuverisMerck Europe B.V.
- CzechiaLUVERISMerck Europe B.V., Amsterdam
- ItalyLUVERIS*1 flaconcino SC 75 UI + 1 flaconcino solvMERCK EUROPE BV
- FinlandLuverisMerck Europe B.V.
- FranceLUVERIS 75 UI, poudre et solvant pour solution injectableMERCK EUROPE (PAYS-BAS)
- United KingdomLuveris 75unit powder and solvent for solution for injection vialsMerck Serono Ltd
- IcelandLuverisMerck Europe B.V.*
- PolandLuverisMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Luveris
- Liechtenstein · Luveris
- Norway · Luveris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca5981c3-8fa3-47ca-bf95-0d93e451a2a7 GET /v1/drugs/ca5981c3-8fa3-47ca-bf95-0d93e451a2a7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Pergoveris 150 IU - 75 IU",
"name_fr": "Pergoveris 150 IU - 75 IU",
"name_nl": "Pergoveris 150 IU - 75 IU",
"amp_code": "SAM301786-00",
"strengths": [
"75.0000",
"150.0000"
],
"pack_count": 3,
"substances": [
"Lutropin Alfa",
"Human Follitropin Alfa, Recombinant",
"Disodium Hydrogen Phosphate Dihydrate",
"Sodium Dihydrogen Phosphate Monohydrate",
"Sodium Hydroxide",
"Sucrose",
"Polysorbate 20"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Combinations",
"authorisation_numbers": [
"EU/1/07/396/002",
"EU/1/07/396/001",
"EU/1/07/396/003"
]
}See everything about gonadotropine, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.